Vitreo Retinal Surgery Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report View Sample

Published: August 21, 2023 Report Code: GDME1603EPD-ST

Select Item

Vitreo Retinal Surgery Devices Pipeline Market Overview

Vitreo Retinal Surgical Devices are used for surgical procedures that treat eye problems involving the retina, macula, and vitreous fluid. The Vitreo Retinal Surgery Devices pipeline market research report provides comprehensive information about the pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress.

Key Territories ·       The US

·       China

·       Europe

·       Singapore

·       Japan

·       Others
Key Regulatory Paths ·       510(k)

·       NMPA

·       CE

·       HSA

·       Shonin

·       ICAC
Leading Companies ·       AcuSurgical

·       Alcon Inc

·       Bausch & Lomb Inc

·       Beaver-Visitec International Inc

·       Boston College

·       Cambridge Polymer Group Inc
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Vitreo Retinal Surgery Devices Pipeline Market Segmentation by Territories

Some of the key territories in the Vitreo Retinal Surgery Devices market are the US, China, Europe, Singapore, Japan, and South Korea among others. As of August 2023, the US accounts for the highest number of Vitreo Retinal Surgery Devices pipeline products.

Vitreo Retinal Surgery Devices Pipeline Market Analysis by Territories, 2023 (%)

Vitreo Retinal Surgery Devices Pipeline Market Analysis by Territories, 2023 (%)

Buy Full Report for More Territory Insights into The Vitreo Retinal Surgery Devices Pipeline Market, Download a Free Report Sample

Vitreo Retinal Surgery Devices Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the Vitreo Retinal Surgery Devices pipeline market are 510(k), NMPA, CE, HSA, Shonin, and ICAC among others. As of August 2023, 510(k) is the most followed pathway for pipeline products.

Vitreo Retinal Surgery Devices Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Vitreo Retinal Surgery Devices Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy Full Report for More Regulatory Path Insights into The Vitreo Retinal Surgery Devices Pipeline Market, Download a Free Report Sample

Vitreo Retinal Surgery Devices Pipeline Market – Competitive Landscape

Some of the key companies in the Vitreo Retinal Surgery Devices pipeline market are AcuSurgical, Alcon Inc, Bausch & Lomb Inc, Beaver-Visitec International Inc, Boston College, and Cambridge Polymer Group Inc among others.

Alcon Inc: Alcon Inc (Alcon) is engaged in the development and manufacturing of devices in the field of ophthalmology. The company’s portfolio encompasses contact lenses and surgical products, including implantables, consumables, and surgical equipment. The company’s products are indicated for the treatment of various conditions such as cataracts, glaucoma, retinal diseases, and refractive errors. It conducts clinical trials to evaluate the safety and efficacy of its products for the prevention and cure of blindness and different eye diseases. Alcon’s pipeline products are developed through collaboration with institutions, medical innovators, research advisors, and academic thought leaders. The company has operations in the Americas, Europe, the Middle East and Africa, and Asia Pacific. Alcon is headquartered in Geneva, Switzerland.

Leading Vitreo Retinal Surgery Devices Companies, 2023

Leading Vitreo Retinal Surgery Devices Companies, 2023Leading Vitreo Retinal Surgery Devices Companies, 2023

Buy Full Report for More Company Insights into The Vitreo Retinal Surgery Devices Pipeline Market, Download a Free Report Sample

Vitreo Retinal Surgery Devices Pipeline Market Segments

Vitreo Retinal Surgery Devices Pipeline Market Territories Outlook

  • China
  • United States
  • Europe
  • Singapore
  • Japan
  • Others

Vitreo Retinal Surgery Devices Pipeline Market Regulatory Paths Outlook

  • NMPA
  • 510(k)
  • CE
  • HSA
  • Shonin
  • ICAC

Scope

This report provides:

  • Extensive coverage of the Vitreo Retinal Surgery Devices under development.

  • Details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.

  • Reviews of the major players involved in the development of Vitreo Retinal Surgery Devices and lists of all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage.

  • Key clinical trial data of ongoing trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.

  • Identify and understand important and diverse types of Vitreo Retinal Surgery Devices under development.

  • Develop market-entry and market-expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

ABVC BioPharma Inc
AcuSurgical
Alcon Inc
Bausch & Lomb Inc
Beaver-Visitec International Inc
Boston College
Cambridge Polymer Group Inc
Carnegie Mellon University
Duke University
Johns Hopkins University
Medisse BV (Inactive)
RetinaSense
Synergetics USA, Inc. (Inactive)
The Chinese University of Hong Kong
Tupai (Beijing) Medical Technology Co Ltd
University of Kansas
University of Minnesota

Table of Contents

  • 1 Table of Contents

    • 1.1 List of Tables

    • 1.2 List of Figures

  • 2 Introduction

    • 2.1 Vitreo Retinal Surgery Devices Overview

  • 3 Products under Development

    • 3.1 Vitreo Retinal Surgery Devices – Pipeline Products by Stage of Development

    • 3.2 Vitreo Retinal Surgery Devices – Pipeline Products by Territory

    • 3.3 Vitreo Retinal Surgery Devices – Pipeline Products by Regulatory Path

    • 3.4 Vitreo Retinal Surgery Devices – Pipeline Products by Estimated Approval Date

    • 3.5 Vitreo Retinal Surgery Devices – Ongoing Clinical Trials

  • 4 Vitreo Retinal Surgery Devices – Pipeline Products under Development by Companies

    • 4.1 Vitreo Retinal Surgery Devices Companies – Pipeline Products by Stage of Development

    • 4.2 Vitreo Retinal Surgery Devices – Pipeline Products by Stage of Development

  • 5 Vitreo Retinal Surgery Devices Companies and Product Overview

    • 5.1 ABVC BioPharma Inc Company Overview

      • 5.1.1 ABVC BioPharma Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 AcuSurgical Company Overview

      • 5.2.1 AcuSurgical Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 Alcon Inc Company Overview

      • 5.3.1 Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 Bausch & Lomb Inc Company Overview

      • 5.4.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 Beaver-Visitec International Inc Company Overview

      • 5.5.1 Beaver-Visitec International Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 Boston College Company Overview

      • 5.6.1 Boston College Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 Cambridge Polymer Group Inc Company Overview

      • 5.7.1 Cambridge Polymer Group Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 Carnegie Mellon University Company Overview

      • 5.8.1 Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 Duke University Company Overview

      • 5.9.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10 Johns Hopkins University Company Overview

      • 5.10.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11 Medisse BV (Inactive) Company Overview

      • 5.11.1 Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12 RetinaSense Company Overview

      • 5.12.1 RetinaSense Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13 Synergetics USA, Inc. (Inactive) Company Overview

      • 5.13.1 Synergetics USA, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14 The Chinese University of Hong Kong Company Overview

      • 5.14.1 The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15 Tupai (Beijing) Medical Technology Co Ltd Company Overview

      • 5.15.1 Tupai (Beijing) Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.16 University of Kansas Company Overview

      • 5.16.1 University of Kansas Pipeline Products & Ongoing Clinical Trials Overview

    • 5.17 University of Minnesota Company Overview

      • 5.17.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview

  • 6 Vitreo Retinal Surgery Devices- Recent Developments

    • 6.1 Jul 13, 2023: Bausch Health to Announce Second-Quarter 2023 Results on Aug. 3

    • 6.2 May 10, 2023: Pixium Vision convenes its annual meeting of shareholders on June 13, 2023

    • 6.3 Apr 25, 2023: Pixium Vision announces the availability of its annual report for the financial year 2022

    • 6.4 Apr 21, 2023: Pixium Vision announces its consolidated financial statements for the financial year 2022 and the consolidated cash balance for March 31, 2023

    • 6.5 Jan 23, 2023: Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2022 Financial Results on February 22

    • 6.6 Oct 04, 2022: Bausch + Lomb Will Release Third-Quarter 2022 Financial Results on November 2

    • 6.7 Sep 28, 2022: Bausch Health Announces Final Results and Expiration of Exchange Offers and Consent Solicitations

    • 6.8 Sep 26, 2022: Bausch & Lomb Will Present New Scientific Data and Analyses During the American Academy of Ophthalmology Annual Meeting

  • 7 Appendix

    • 7.1 Methodology

    • 7.2 About GlobalData

    • 7.3 Contact Us

    • 7.4 Disclaimer

Table

Vitreo Retinal Surgery Devices – Pipeline Products by Stage of Development 9

Vitreo Retinal Surgery Devices – Pipeline Products by Territory 10

Vitreo Retinal Surgery Devices – Pipeline Products by Regulatory Path 11

Vitreo Retinal Surgery Devices – Pipeline Products by Estimated Approval Date 12

Vitreo Retinal Surgery Devices – Ongoing Clinical Trials 13

Vitreo Retinal Surgery Devices Companies – Pipeline Products by Stage of Development 14

Vitreo Retinal Surgery Devices – Pipeline Products by Stage of Development 15

ABVC BioPharma Inc Pipeline Products & Ongoing Clinical Trials Overview 16

Vitargus – Product Status 16

Vitargus – Product Description 17

ABVC BioPharma Inc – Ongoing Clinical Trials Overview 18

Vitargus – A Prospective Multi-Site Open Label Randomized Controlled Clinical Investigation of the Safety and Effectiveness of the ABV-1701 Ocular Endotamponade (OE) 19

AcuSurgical Pipeline Products & Ongoing Clinical Trials Overview 20

Robotic Surgical Assistant – Product Status 20

Robotic Surgical Assistant – Product Description 20

Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview 21

Finesse Reflex Handle – Product Status 21

Finesse Reflex Handle – Product Description 22

New CONSTELLATION Vitreoretinal System – Product Status 22

New CONSTELLATION Vitreoretinal System – Product Description 22

Next Generation Vitreo-retinal System – Product Status 23

Next Generation Vitreo-retinal System – Product Description 23

Next-Generation Phaco Vit-Ret Console – Product Status 23

Next-Generation Phaco Vit-Ret Console – Product Description 23

Ngenuity 2.0 – Product Status 24

Ngenuity 2.0 – Product Description 24

Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 25

BLS – 009: Retina – Product Status 25

BLS – 009: Retina – Product Description 26

BLS-005: Retina – Product Status 26

BLS-005: Retina – Product Description 26

BLS-012: Retina – Product Status 26

BLS-012: Retina – Product Description 27

BLS-013: Retina – Product Status 27

BLS-013: Retina – Product Description 27

BLS-018: Retina – Product Status 27

BLS-018: Retina – Product Description 28

BLS-019: Retina – Product Status 28

BLS-019: Retina – Product Description 28

BLS-020: Retina – Product Status 28

BLS-020: Retina – Product Description 29

BLS-021: Retina – Product Status 29

BLS-021: Retina – Product Description 29

BLS-022: Retina – Product Status 29

BLS-022: Retina – Product Description 30

BLS-023: Retina – Product Status 30

BLS-023: Retina – Product Description 30

BLS-024: Retina – Product Status 30

BLS-024: Retina – Product Description 31

BLS-025: Retina – Product Status 31

BLS-025: Retina – Product Description 31

BLS-026: Retina – Product Status 31

BLS-026: Retina – Product Description 32

BLS-027: Retina – Product Status 32

BLS-027: Retina – Product Description 32

BLS-028: Retina – Product Status 32

BLS-028: Retina – Product Description 33

BLS-029: Retina – Product Status 33

BLS-029: Retina – Product Description 33

BLS-030: Retina – Product Status 33

BLS-030: Retina – Product Description 34

BLS-031: Retina – Product Status 34

BLS-031: Retina – Product Description 34

Beaver-Visitec International Inc Pipeline Products & Ongoing Clinical Trials Overview 35

Velvet – Product Status 35

Velvet – Product Description 35

Boston College Pipeline Products & Ongoing Clinical Trials Overview 36

Visual Prosthetic Device – Product Status 36

Visual Prosthetic Device – Product Description 36

Cambridge Polymer Group Inc Pipeline Products & Ongoing Clinical Trials Overview 37

Retinal Tamponade – Product Status 37

Retinal Tamponade – Product Description 37

Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview 38

Micron – Product Status 38

Micron – Product Description 38

Duke University Pipeline Products & Ongoing Clinical Trials Overview 39

Secure Locking Cannula – Product Status 39

Secure Locking Cannula – Product Description 39

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 40

Microsurgical Tool – Product Status 40

Microsurgical Tool – Product Description 40

Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 41

PTMC Scleral Buckle – Product Status 41

PTMC Scleral Buckle – Product Description 41

RetinaSense Pipeline Products & Ongoing Clinical Trials Overview 42

RetinaSense Device – Product Status 42

RetinaSense Device – Product Description 42

Synergetics USA, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 43

Intraoperative Device – Product Status 43

Intraoperative Device – Product Description 43

The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 44

Scleral Buckles – Product Status 44

Scleral Buckles – Product Description 44

Tupai (Beijing) Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 45

Ultra-Milk Vitrectomy Machine – Product Status 45

Ultra-Milk Vitrectomy Machine – Product Description 45

University of Kansas Pipeline Products & Ongoing Clinical Trials Overview 46

Subretinal Fluid Drainage Cannula – Product Status 46

Subretinal Fluid Drainage Cannula – Product Description 46

University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 47

Scleral Depressor System – Product Status 47

Scleral Depressor System – Product Description 47

Glossary 56

Figures

Vitreo Retinal Surgery Devices – Pipeline Products by Stage of Development 9

Vitreo Retinal Surgery Devices – Pipeline Products by Territory 10

Vitreo Retinal Surgery Devices – Pipeline Products by Regulatory Path 11

Vitreo Retinal Surgery Devices – Pipeline Products by Estimated Approval Date 12

Vitreo Retinal Surgery Devices – Ongoing Clinical Trials 13

Frequently asked questions

Vitreo Retinal Surgery Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Vitreo Retinal Surgery Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Vitreo Retinal Surgery Devices reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Vitreo Retinal Surgery Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Vitreo Retinal Surgery Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more